Y. Wada

Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis

M. Nojima, Kenshi Suzuki, Y. Sagesaka, 2017, International Journal of Hematology.

Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products.

H. Seo, V. Monnier, T. Miyata, 1996, Kidney international.

Glycation of human beta 2-microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites.

N. Taniguchi, T. Miyata, R. Inagi, 1994, Biochemistry.

Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.

Y. Wada, T. Miyata, K. Horie, 1997, Kidney international.

Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens’ antibacterial susceptibility

Y. Nakanishi, M. Fujita, M. Terada, 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.